Biocartis Clinical Performance Evaluation Study in Sierra Leone of the Biocartis Idylla System with the Rapid Ebola Virus Triage Test

计划入组 300 人

KEBI-Cyto Study - Use of the Biocartis Idylla

计划入组 55 人 · 首次发布于 2020 年 1 月 22 日

A First-in-human Trial to Assess the Safety and Performance of the BioCaptis in Healthy Volunteers

计划入组 18 人 · 首次发布于 2023 年 4 月 14 日

CD73 inhibitor(BioArdis)

MRGPRX2 Antagonist(BioArdis)

CardiALLO cell therapy (BioCardia)

BioCardia

United States

Biofortis, Merieux NutriSciences

Biocartis and City of Hope Partner to Develop Rapid Blood-Based Gene Signature Test for Early Pancreatic Cancer Detection

Biocartis Receives FDA Approval for First Fully Automated Companion Diagnostic Test for Colorectal Cancer

Biocartis Achieves First IVDR Class C Companion Diagnostic Certification for EGFR Mutation Test in Europe